Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9795-9811
Closed Access | Times Cited: 14

Showing 14 citing articles:

An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents
B. Kumaraswamy, K. Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116561-116561
Closed Access | Times Cited: 7
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 6
Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure–activity relationship
Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das, et al.
Molecular Diversity (2025)
Closed Access
Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study
Linxiao Wang, Dang Fan, Wei Ruan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 2
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 2
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 7
Anticancer and antibacterial Activeness of fused Pyrimidines: Newfangled Updates
Ayushi Bhatnagar, Gangotri Pemawat
Bioorganic Chemistry (2024) Vol. 153, pp. 107780-107780
Closed Access | Times Cited: 1
Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 1
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship
E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access
Recent advancements in mechanistic Research, therapeutic Potential, and Structure-Activity relationships of Aurora kinase inhibitors in cancer therapies
Ghanshyam Teli, Lalmohan Maji, Rohit Pal, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107976-107976
Closed Access
Page 1

Scroll to top